Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.
about
Molecular mechanism underlying lymphatic metastasis in pancreatic cancerCC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma.CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells.The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer.STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma.Pancreatic cancer stem cells - update and future perspectives.Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer.Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma.Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.The chemotactic interaction between CCL21 and its receptor, CCR7, facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma.MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway.CCR7 regulates ANO6 to promote migration of pancreatic ductal adenocarcinoma cells via the ERK signaling pathway.
P2860
Q26999345-6630EC3C-84E1-4707-AA33-35C0D00CFB54Q33559862-99510422-2614-45C2-B795-8803573A7247Q35583823-E74197E6-610C-41D7-BE47-6531C8DAC00CQ35753643-8130E2B2-8AFF-436A-8898-9296E11611CCQ36163212-41290C47-C3CC-4D9D-9837-CE1CF389D1B0Q36502337-37781C8A-6EA4-4D9D-8BD5-96BA2A25F3BDQ37366527-37D1DA2E-1840-4CEE-A17E-F6F18137B663Q37767915-F4258CF5-8833-4446-8C81-50BD2B7EDB7DQ37885319-B4DD4A4F-73AF-4AC4-9682-CBC888B8F390Q38249887-30E86085-73BE-4116-8D05-3C6254BF29F6Q39454058-9E812F9C-8FD5-4202-A92B-D8BA6FE640FAQ39540035-C991A7BD-749F-4EA8-8E7C-E884BA285804Q39706220-4B9E38B0-B33C-4BEA-94B0-47548D0167DEQ42149105-DA32B975-4CC8-4E24-A732-107C42C53C42Q47298145-A44C5D12-7B69-416C-804C-17F89F7D8C65Q55667705-9EE8FEE4-DEB5-48C9-AF2D-7D5164C47134
P2860
Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Chemokine receptor CCR7 expres ...... tastasis in pancreatic cancer.
@en
Chemokine receptor CCR7 expres ...... tastasis in pancreatic cancer.
@nl
type
label
Chemokine receptor CCR7 expres ...... tastasis in pancreatic cancer.
@en
Chemokine receptor CCR7 expres ...... tastasis in pancreatic cancer.
@nl
prefLabel
Chemokine receptor CCR7 expres ...... tastasis in pancreatic cancer.
@en
Chemokine receptor CCR7 expres ...... tastasis in pancreatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
Chemokine receptor CCR7 expres ...... tastasis in pancreatic cancer.
@en
P2093
Bunzo Nakata
Kosei Hirakawa
Nobuya Yamada
Ryosuke Amano
Shinya Fukunaga
P2860
P356
10.1159/000139126
P577
2008-06-11T00:00:00Z